Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

Novartis today announced that the US Food and Drug Administration (FDA) has approved Itvisma® (onasemnogene abeparvovec-brve) for the treatment of children two years and older, teens, and adults ...

The 6 Best Performances We Saw at the 2025 New York Comedy Festival

Louis C.K, Alex Edelman, Morgan Jay and the 'St. Denis Medical' and 'Strangers with Candy' casts brought big laughs to the ...
The Hearty Soul on MSN

Researchers Verify Classic Theory on Why People With Schizophrenia Hear Voices

Many people live with a secret that feels almost impossible to describe. They hear speech or whispers that nobody else ...